{
    "clinical_study": {
        "@rank": "141208", 
        "acronym": "DME FOUND", 
        "arm_group": {
            "arm_group_label": "OCT imaging", 
            "arm_group_type": "Experimental", 
            "description": "All study participants will undergo optical coherence tomography imaging and will be referred to a retina specialist for further standard care evaluation and management if they are identified as having diabetic macular edema or the scan quality is not sufficient to evaluate macular status."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this protocol is to determine whether point of care optical coherence\n      tomography (OCT) imaging combined with an OCT-guided retinal referral algorithm at primary\n      diabetes care visits increases rates of retina specialist eye care for patients with\n      diabetic macular edema.  The hypothesis is that OCT imaging with an automated OCT-guided\n      referral algorithm will enable identification of patients at risk for vision loss from\n      diabetic macular edema and facilitate direct referral to retina specialists for more timely\n      evaluation and treatment."
        }, 
        "brief_title": "OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits", 
        "condition": [
            "Diabetes", 
            "Diabetic Macular Edema", 
            "Diabetic Retinopathy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetic Retinopathy", 
                "Edema", 
                "Macular Edema", 
                "Retinal Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Type 1 or type 2 diabetes mellitus as evidenced by:\n\n          -  Current regular use of insulin or oral anti-hyperglycemia agents for the treatment of\n             diabetes OR\n\n          -  Documented diabetes by American Diabetes Association and/or World Health Organization\n             criteria\n\n          -  Age greater than or equal to 18 years old\n\n          -  Diabetes duration of 10 more years OR last measured HbA1c of 10% or more\n\n          -  Able and willing to participate in study procedures and comply with study follow-up\n             visits\n\n          -  Able to give informed consent for study participation\n\n          -  Not moving out of the study area during the 1 year follow-up period\n\n        Exclusion Criteria:\n\n          -  Unable to cooperate with the OCT image acquisition procedure or other study\n             procedures\n\n          -  Unable or unwilling to comply with the study follow-up visits\n\n          -  Unable or unwilling to sign form for release of retinal medical records"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "380", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01875783", 
            "org_study_id": "2011-17"
        }, 
        "intervention": {
            "arm_group_label": "OCT imaging", 
            "description": "Optical coherence tomography (OCT) imaging is a noninvasive, rapid, and readily performed method for evaluating the anatomy of the central retina.", 
            "intervention_name": "OCT imaging", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "diabetes", 
            "diabetic macular edema", 
            "diabetic retinopathy", 
            "optical coherence tomography"
        ], 
        "lastchanged_date": "August 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02215"
                }, 
                "name": "Joslin Diabetes Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits", 
        "overall_contact": {
            "email": "jennifer.sun@joslin.harvard.edu", 
            "last_name": "Jennifer K Sun, MD", 
            "phone": "617-309-2554"
        }, 
        "overall_official": {
            "affiliation": "Joslin Diabetes Center", 
            "last_name": "Jennifer K Sun, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Percentage of participants who follow-up with a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm as compared with the percentage of patients currently receiving retina eye care (assessed by study participant self-report as well as by determination of historical retina eye care rates from documentation in the medical records of study-eligible patients seen within the previous 6 months)", 
            "measure": "Rates of retina care for patients with diabetic macular edema", 
            "safety_issue": "No", 
            "time_frame": "Baseline visit"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01875783"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Percentage of participants who are referred to a retina specialist for evaluation and management of DME after OCT imaging and OCT-guided referral algorithm as compared with independently recorded \"standard care\" referrals to retina specialists by diabetologists masked to OCT results", 
                "measure": "Retinal referral rates for patients with DME", 
                "safety_issue": "No", 
                "time_frame": "Baseline visit"
            }, 
            {
                "description": "Percentage of participants are referred by OCT-guided algorithm who receive treatment or are scheduled for treatment for DME at first visit with retina specialist after study enrollment", 
                "measure": "Rates of retinal treatment for patients with DME", 
                "safety_issue": "No", 
                "time_frame": "One month"
            }, 
            {
                "description": "Percentage of participants who are referred by OCT guided algorithm to a retina specialist who receive treatment for DME over the course of 1 year follow-up by retina specialist", 
                "measure": "Rates of retinal treatment over 1 year for patients with DME", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Joslin Diabetes Center", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Genentech", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Juvenile Diabetes Research Foundation", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Optovue", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Joslin Diabetes Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}